Results 11 to 20 of about 43,186 (297)

Shift work and use of psychotropic medicine: a follow-up study with register linkage [PDF]

open access: hybridScandinavian Journal of Work, Environment & Health, 2020
OBJECTIVE: This study aimed to investigate a prospective association between shift work and use of psychotropic medicine. METHODS: Survey data from random samples of the general working population of Denmark (N=19 259) were linked to data from national ...
Karen Albertsen   +3 more
doaj   +4 more sources

Evaluation of the effect of managing oxycodone/acetaminophen as a psychotropic medicine: An interrupted time-series study [PDF]

open access: yesFrontiers in Pharmacology, 2023
Background: Oxycodone/acetaminophen has been reported for misuse for many times in China. To cope with that, Chinese national authorities jointly issued a policy, requiring that oxycodone/acetaminophen should be managed as a psychotropic medicine ...
Cheng Xiang   +13 more
doaj   +2 more sources

Long working hours and use of psychotropic medicine: a follow-up study with register linkage

open access: hybridScandinavian Journal of Work, Environment & Health, 2016
OBJECTIVE: This study aimed to investigate the possibility of a prospective association between long working hours and use of psychotropic medicine. METHODS: Survey data drawn from random samples of the general working population of Denmark in the time ...
Harald Hannerz, Karen Albertsen
doaj   +3 more sources

Psychotropic complementary medicines [PDF]

open access: bronzeBritish Journal of Psychiatry, 2006
The recent review by Werneke et al ([2006][1]) contains substantive errors and omissions regarding the iboga alkaloid ibogaine and its synthetic congener 18-methoxycoronaridine (18-MC). The review cites a single paper published in 1994 consisting of seven case reports and overlooks two ...
K. R. Alper, S. D. Glick
openaire   +2 more sources

Psychological medicine. Psychotropic drugs in general practice. [PDF]

open access: bronzeBMJ, 1975
Earlier articles in this series have examined the indications for prescribing in a wide range of diseases and for defined prob lems in the hospital setting and in general practice. They have highlighted the side effects of most relevance to the patient and to try to repeat or even summarize this information would be regarded as unnecessary.
J. G. R. Howie
openaire   +4 more sources

Resisting psychotropic medicines: a synthesis of qualitative studies of medicine-taking [PDF]

open access: bronzeAdvances in Psychiatric Treatment, 2010
SummaryThis article reports the results of a synthesis of qualitative research articles about lay perspectives on prescribed psychotropic medicines. It updates and elaborates on a model of medicine-taking developed by Pound and colleagues. In this model, the concept of resistance refers to the various ways in which people take prescribed medicines ...
Nicky Britten   +2 more
openaire   +2 more sources

Psychiatrists and non-psychiatrists’ attitudes to psychotropic optimisation for people with intellectual disabilities and/or autism: cross-sectional comparison study [PDF]

open access: yesBJPsych Open
Background Off-licence psychotropic use in people with intellectual disability and/or autism, in the absence of psychiatric illness, is a major public health concern in England.
Samuel J. Tromans   +12 more
doaj   +2 more sources

Psychotropic medication and in-hospital falls in older adults: a cohort-based secondary analysis with exploratory stratification among users [PDF]

open access: yesScientific Reports
People using psychotropic medication have a higher risk of falls in the hospital environment. This study aims to investigate and assess the risk of falls in the people using psychotropic medication in hospitals.
Maosong Wang, Jifeng Peng, Jianxin Hu
doaj   +2 more sources

Safety of psychotropic medicines: contribution from observational evidence [PDF]

open access: bronzeEpidemiology and Psychiatric Sciences, 2018
The risks associated with psychotropic drugs use should be accurately documented at the population level in view of the growing number of persons exposed to these drugs. The strengths of observational studies regarding the identification of drug-related harms mirror the limitations of randomised controlled trials and vice-versa.
Hélène Verdoux
openaire   +3 more sources

Home - About - Disclaimer - Privacy